When was SeqOne founded?

SeqOne was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Where is SeqOne located?

SeqOne is headquartered in Montpellier, France.

How many employees does SeqOne have?

As of May 31, 2026, the latest employee count at SeqOne is 108.

Is SeqOne a funded company?

SeqOne is a funded company, having raised a total of $48.8M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 28, 2019.

When was the latest funding round of SeqOne?

SeqOne's latest funding was a $***** Series A round on May 26, 2025, with participation from 4 investors.

Where does SeqOne rank among its competitors?

SeqOne ranks 16th amongst 1521 active competitors, of which 219 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of SeqOne?

SeqOne's top competitors include Strand Life Sciences, Benchling and Helix. Among them, SeqOne secured the most recent funding round in May, 2025.

SeqOne - 2026 Company Profile, Team, Funding & Competitors

SeqOne is a series A company based in Montpellier (France), founded in 2017. It operates as a Provider of bioinformatics tools for the analysis of genome sequencing data. SeqOne has raised $48.8M in funding from investors like Elaia, Omnes Capital and Supernova Invest. The company has 1521 active competitors, including 219 funded and 138 that have exited. Its top competitors include companies like Strand Life Sciences, Benchling and Helix.

Company Details

Provider of bioinformatics tools for the analysis of genome sequencing data. The platform helps researchers to detect & identify the variants responsible for gene mutation. It helps to detect many types of variants such as SNPs, Indels, CNVs, and mid-sized deletions.

Website: www.seqone.com/
Social
Email ID: *****@seqone.com
Phone Number: +33 **********

Key Metrics

Founded Year

2017

Location

Montpellier, France

Stage

Series A

Total Funding

$48.8M in 3 rounds

Latest Funding Round

Series A, May 26, 2025, $*****

Investors

Elaia & 8 more

Ranked

16^th among 1521 active competitors

Employee Count

108 as on May 31, 2026

Investment & Acquisitions

Congenica

Similar Companies

Benchling & 1146 more

View SeqOne's full profile

SeqOne has raised a total funding of $48.8M over 3 rounds. Its first funding round was on Mar 28, 2019. Its latest funding round was a Series A round on May 26, 2025 for $*****. 4 investors participated in its latest round. SeqOne has 9 institutional investors.

Here is the list of recent funding rounds of SeqOne:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 26, 2025	3070871	Series A	8947355	2038061	8564629	8627921
Jan 24, 2022	3461585	Series A	3106897	1731593	8487413	Software Club & 2 more
Mar 28, 2019	8282120	Series A	2495232	7872813	Elaia	IRDI Soridec Gestion & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of SeqOne's funding rounds and investors

SeqOne's employee count trend

SeqOne has 108 employees as of May 26. Here is SeqOne's employee count trend over the years:

Uncover SeqOne's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SeqOne include Strand Life Sciences, Benchling and Helix. Here is the list of Top 10 competitors of SeqOne, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 92 others	73/100
2nd	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Menlo Ventures & 28 others	73/100
3rd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
4th	Tessera Therapeutics 2017, Cambridge (United States), Series C	Provider of new genome engineering technology for treating multiple diseases	$610M	T. Rowe Price, ADIA & 22 others	64/100
5th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Sequoia Capital China, Yunfeng Capital & 15 others	64/100
6th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	Khosla Ventures, SoftBank Vision Fund & 16 others	63/100
7th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	The Column Group, Nextech Invest & 10 others	63/100
8th	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	IDO Investments, Xeraya Capital & 39 others	62/100
9th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	60/100
10th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Perceptive Advisors, Domain Associates & 5 others	60/100
16th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Bpifrance, Supernova Invest & 7 others	57/100